Zhang, X., Liu, D., Li, M., Cao, C., Wan, D., Xi, B., . . . Gao, Q. (2017). Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer. J Hematol Oncol.
Citación estilo ChicagoZhang, Xiaoxue, et al. "Prognostic and Therapeutic Value of Disruptor of Telomeric Silencing-1-like (DOT1L) Expression in Patients With Ovarian Cancer." J Hematol Oncol 2017.
Cita MLAZhang, Xiaoxue, et al. "Prognostic and Therapeutic Value of Disruptor of Telomeric Silencing-1-like (DOT1L) Expression in Patients With Ovarian Cancer." J Hematol Oncol 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.